Enveric Biosciences Inc
(NQ:
ENVB
)
0.5280
+0.0581 (+12.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,080,288
Open
0.4565
Bid (Size)
0.5154 (7)
Ask (Size)
0.5200 (11)
Prev. Close
0.4699
Today's Range
0.4501 - 0.5580
52wk Range
0.4100 - 3.898
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
Via
Benzinga
Why Is Imunon (IMNN) Stock Up 259% Today?
July 30, 2024
Imunon stock is up on Tuesday with heavy trading of IMNN shares after posting positive results from a Phase 2 clinical trial.
Via
InvestorPlace
Performance
YTD
-58.10%
-58.10%
1 Month
-4.38%
-4.38%
3 Month
-42.95%
-42.95%
6 Month
-41.55%
-41.55%
1 Year
-79.85%
-79.85%
More News
Read More
Why Is Ekso Bionics (EKSO) Stock Down 15% Today?
July 30, 2024
Via
InvestorPlace
Why Is Enveric Biosciences (ENVB) Stock Up 18% Today?
July 30, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
July 30, 2024
Via
InvestorPlace
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
July 30, 2024
Via
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
July 25, 2024
Via
Benzinga
Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally
July 25, 2024
From
Enveric Biosciences
Via
Business Wire
Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement
July 15, 2024
From
Enveric Biosciences
Via
Business Wire
New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
July 11, 2024
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Enveric Biosciences Announces Patent Granted for Drug Candidate
July 10, 2024
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate
June 25, 2024
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences to Participate in BIO International Convention 2024
May 30, 2024
From
Enveric Biosciences
Via
Business Wire
ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q1 2024
May 20, 2024
Via
InvestorPlace
'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
May 16, 2024
Via
Benzinga
Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results
May 15, 2024
From
Enveric Biosciences
Via
Business Wire
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
May 14, 2024
Via
Benzinga
Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
May 14, 2024
From
Enveric Biosciences
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 08, 2024
Via
Benzinga
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
May 08, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
May 08, 2024
From
Enveric Biosciences
Via
Business Wire
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
April 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 02, 2024
Via
Benzinga
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 03, 2024
Via
Benzinga
Exposures
Glyphosate
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.